THERASOFT INC. – Trademark Portfolio
Entity Type: 03
THERASOFT INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THERASOFT. The owner is based in SEATTLE, WA.
1420 5TH AVE STE 2200
SEATTLE, WA 98101
Showing of trademarks Trademarks
Trademark Classifications
THERASOFT INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does THERASOFT INC. have?
THERASOFT INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does THERASOFT INC. file in?
THERASOFT INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are THERASOFT INC.'s most well-known trademarks?
THERASOFT INC.'s registered trademark portfolio includes well-known marks such as THERASOFT. These are among 1 currently registered trademark in the portfolio.
What is THERASOFT INC.'s trademark registration success rate?
THERASOFT INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.